Working… Menu

Study of Azacitidine and Durvalumab in Advanced Solid Tumors (METADUR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02811497
Recruitment Status : Completed
First Posted : June 23, 2016
Last Update Posted : April 1, 2021
Information provided by (Responsible Party):
University Health Network, Toronto